Respiratory syncytial virus infection: Pathogenesis, treatment and prevention

被引:6
|
作者
Simoes, EAF
机构
[1] University of Colorado, School of Medicine, Children's Hospital, Denver, CO 80218, 1056 E. 19th Ave.
关键词
D O I
10.1097/00001432-199706000-00010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Respiratory syncytial virus is the most important viral cause of lower respiratory infections in children worldwide. Our current understanding of the pathogenesis of disease is based on animal models and a few human studies. The development of an infectious cDNA of respiratory syncytial virus promises to give a better understanding of the genetic basis of the pathogenesis of the virus, and will allow for the manipulation of the genome, Presently the only preventive measure available is a respiratory syncytial virus hyperimmune globulin that is effective in high-risk children. No effective therapeutic interventions or vaccines are currently available.
引用
收藏
页码:213 / 220
页数:8
相关论文
共 50 条
  • [31] Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus
    Empey, Kerry M.
    Peebles, R. Stokes, Jr.
    Kolls, Jay K.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (09) : 1258 - 1267
  • [32] Respiratory syncytial virus disease: update on treatment and prevention
    Krilov, Leonard R.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (01) : 27 - 32
  • [33] Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children
    Eric A. F. Simões
    Louis Bont
    Paolo Manzoni
    Brigitte Fauroux
    Bosco Paes
    Josep Figueras-Aloy
    Paul A. Checchia
    Xavier Carbonell-Estrany
    [J]. Infectious Diseases and Therapy, 2018, 7 : 87 - 120
  • [34] Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date
    Charl Verwey
    Ziyaad Dangor
    Shabir A. Madhi
    [J]. Pediatric Drugs, 2024, 26 : 101 - 112
  • [35] Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection
    Mejias, Asuncion
    Garcia-Maurino, Cristina
    Rodriguez-Fernandez, Rosa
    Peeples, Mark E.
    Ramilo, Octavio
    [J]. VACCINE, 2017, 35 (03) : 496 - 502
  • [36] Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
    Gatt, Dvir
    Martin, Isaac
    AlFouzan, Rawan
    Moraes, Theo J. J.
    [J]. PATHOGENS, 2023, 12 (02):
  • [37] The Future of Respiratory Syncytial Virus Disease Prevention and Treatment
    Joseph B. Domachowske
    Evan J. Anderson
    Mitchell Goldstein
    [J]. Infectious Diseases and Therapy, 2021, 10 : 47 - 60
  • [38] Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus
    Sun, Bo-Wen
    Zhang, Peng-Peng
    Wang, Zong-Hao
    Yao, Xia
    He, Meng-Lan
    Bai, Rui-Ting
    Che, Hao
    Lin, Jing
    Xie, Tian
    Hui, Zi
    Ye, Xiang-Yang
    Wang, Li-Wei
    [J]. MOLECULES, 2024, 29 (03):
  • [39] Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children
    Simoes, Eric A. F.
    Bont, Louis
    Manzoni, Paolo
    Fauroux, Brigitte
    Paes, Bosco
    Figueras-Aloy, Josep
    Checchia, Paul A.
    Carbonell-Estrany, Xavier
    [J]. INFECTIOUS DISEASES AND THERAPY, 2018, 7 (01) : 87 - 120
  • [40] Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date
    Verwey, Charl
    Dangor, Ziyaad
    Madhi, Shabir A.
    [J]. PEDIATRIC DRUGS, 2024, 26 (02) : 101 - 112